Related Experiment Video
Updated: Aug 27, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Transient paroxysmal dystonia in an infant possibly induced by cisapride
1Divisione di Neuropsichiatria Infantile, Istituto Nazionale Neurologico, C. Besta, Milano, Italy.
Insights
This case report details an infant experiencing paroxysmal dystonia while on cisapride treatment. Researchers suggest cisapride may cause extrapyramidal symptoms by affecting brain neurotransmitters in infants.
Area of Science:
- Pediatric Neurology
- Pharmacology
- Neuroscience
Background:
- Cisapride is a widely used medication for infant gastrointestinal disorders.
- Extrapyramidal symptoms, such as dystonia, are movement disorders affecting motor control.
Abstract:
The case is reported of an infant presenting paroxysmal dystonia during cisapride theraphy. We suggest that this drug, a substituted benzamide, probably interfered with the age-related modification of striatal neurotransmitters, provoking extrapyramidal symptoms. Considering the widespread use of cisapride in early infancy for the treatment of gastrointestinal disorders, attention must be drawn to this possible side effect.
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drugs for Treatment of Constipation-Predominant IBS
Tetanus
Alterations in Muscle Tone ll

